JKC 301
JKC 301 is a selective endothelin A (ETA) receptor antagonist. It effectively reduces nicotine-induced pressor responses in vivo, making it a valuable research tool for investigating smoking-related cardiovascular pathologies in both in vitro and in vivo experimental models.
Product Specifications
Field of Research
Pharmacology & Drug Discovery
Molecular Weight
624.73
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog